2024.12


Release time:

2025-01-10

Nanolattix T320 Cancer Drug Successfully Receives U.S. FDA Clinical Approval

2024.12

Nanolattix T320 Cancer Drug Successfully Receives U.S. FDA Clinical Approval

Tag:


Previous Page

Next Page

Previous Page:

Next page: